Miller C H, Hummer M, Oberbauer H, Kurzthaler I, DeCol C, Fleischhacker W W
Department of Biological Psychiatry, Innsbruck University Clinics, Austria.
Eur Neuropsychopharmacol. 1997 Feb;7(1):51-5. doi: 10.1016/s0924-977x(96)00041-7.
Neuroleptic induced akathisia (NIA) is a common and distressing side effect of antipsychotic treatment. Incidence rates are reported to be between 25% and 75%, depending on criteria used for diagnosis. The results of our four week prospective naturalistic study are based on the assessment of 73 inpatients, which were started on antipsychotic medication in one of the inpatient units of the Department of Psychiatry. NIA was rated with the Hillside Akathisia Scale. Assuming that both, objective as well subjective phenomena are necessary for a valid diagnosis of NIA, we calculated an incidence rate of 22.4%. 75% of all NIA cases occurred within the first three days of antipsychotic treatment. When attempting to determine risk factors for the development of NIA, we found a significant influence of dose increase in the first days of treatment.
抗精神病药物所致静坐不能(NIA)是抗精神病治疗常见且令人苦恼的副作用。据报道,其发生率在25%至75%之间,具体取决于诊断标准。我们为期四周的前瞻性自然主义研究结果基于对73名住院患者的评估,这些患者在精神病科的一个住院单元开始接受抗精神病药物治疗。使用山坡静坐不能量表对NIA进行评分。假设客观和主观现象对于NIA的有效诊断均必不可少,我们计算出的发生率为22.4%。所有NIA病例的75%发生在抗精神病治疗的头三天内。在试图确定NIA发生的风险因素时,我们发现治疗开始头几天剂量增加有显著影响。